A detailed history of Eads & Heald Wealth Management transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Eads & Heald Wealth Management holds 2,664 shares of IDXX stock, worth $1.29 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
2,664
Previous 2,807 5.09%
Holding current value
$1.29 Million
Previous $1.56 Million 7.7%
% of portfolio
0.67%
Previous 0.75%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$515.08 - $576.87 $73,656 - $82,492
-143 Reduced 5.09%
2,664 $1.44 Million
Q4 2023

Jan 30, 2024

SELL
$391.37 - $557.56 $19,568 - $27,877
-50 Reduced 1.75%
2,807 $1.56 Million
Q3 2023

Oct 27, 2023

SELL
$432.42 - $556.67 $30,269 - $38,966
-70 Reduced 2.39%
2,857 $1.25 Million
Q2 2023

Jul 25, 2023

SELL
$450.7 - $503.61 $67,605 - $75,541
-150 Reduced 4.87%
2,927 $1.47 Million
Q1 2023

Apr 21, 2023

SELL
$406.01 - $514.59 $92,164 - $116,811
-227 Reduced 6.87%
3,077 $1.54 Million
Q4 2022

Jan 27, 2023

SELL
$324.64 - $441.27 $7,466 - $10,149
-23 Reduced 0.69%
3,304 $1.35 Million
Q3 2022

Oct 27, 2022

SELL
$325.8 - $407.78 $11,728 - $14,680
-36 Reduced 1.07%
3,327 $1.08 Million
Q2 2022

Jul 26, 2022

BUY
$327.37 - $553.44 $228,504 - $386,301
698 Added 26.19%
3,363 $1.18 Million
Q1 2022

Apr 27, 2022

SELL
$466.52 - $631.01 $3,265 - $4,417
-7 Reduced 0.26%
2,665 $1.46 Million
Q4 2021

Jan 31, 2022

SELL
$586.54 - $666.48 $6,451 - $7,331
-11 Reduced 0.41%
2,672 $1.76 Million
Q3 2021

Oct 27, 2021

SELL
$621.9 - $705.76 $172,266 - $195,495
-277 Reduced 9.36%
2,683 $1.67 Million
Q2 2021

Jul 30, 2021

SELL
$486.36 - $637.08 $152,230 - $199,406
-313 Reduced 9.56%
2,960 $1.87 Million
Q1 2021

Apr 29, 2021

SELL
$465.18 - $551.79 $109,782 - $130,222
-236 Reduced 6.73%
3,273 $1.6 Million
Q4 2020

Feb 02, 2021

SELL
$383.85 - $499.87 $231,077 - $300,921
-602 Reduced 14.64%
3,509 $1.75 Million
Q3 2020

Nov 02, 2020

SELL
$334.54 - $406.31 $332,532 - $403,872
-994 Reduced 19.47%
4,111 $1.62 Million
Q2 2020

Jul 29, 2020

SELL
$230.66 - $330.16 $135,858 - $194,464
-589 Reduced 10.34%
5,105 $1.69 Million
Q1 2020

May 01, 2020

SELL
$182.94 - $290.97 $32,380 - $51,501
-177 Reduced 3.01%
5,694 $1.38 Million
Q4 2019

Jan 31, 2020

BUY
$248.66 - $285.01 $18,898 - $21,660
76 Added 1.31%
5,871 $1.53 Million
Q3 2019

Oct 31, 2019

SELL
$260.07 - $289.93 $8,842 - $9,857
-34 Reduced 0.58%
5,795 $1.58 Million
Q2 2019

Jul 30, 2019

SELL
$215.53 - $275.33 $109,273 - $139,592
-507 Reduced 8.0%
5,829 $0
Q1 2019

Apr 26, 2019

BUY
$178.02 - $225.69 $6,230 - $7,899
35 Added 0.56%
6,336 $0
Q4 2018

Jan 31, 2019

SELL
$176.18 - $248.92 $6,871 - $9,707
-39 Reduced 0.62%
6,301 $1.17 Million
Q3 2018

Oct 31, 2018

SELL
$218.82 - $254.46 $216,850 - $252,169
-991 Reduced 13.52%
6,340 $0
Q2 2018

Jul 27, 2018

BUY
$185.56 - $227.9 $72,925 - $89,564
393 Added 5.66%
7,331 $0
Q1 2018

Apr 26, 2018

SELL
$157.81 - $204.73 $84,428 - $109,530
-535 Reduced 7.16%
6,938 $0
Q4 2017

Jan 31, 2018

BUY
$147.68 - $168.37 $4,430 - $5,051
30 Added 0.4%
7,473 $0
Q3 2017

Oct 27, 2017

BUY
$150.32 - $166.46 $1.12 Million - $1.24 Million
7,443
7,443 $0

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $40.5B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Eads & Heald Wealth Management Portfolio

Follow Eads & Heald Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.